Nutrition issues in pediatric Crohn's disease

Nutrition in Clinical Practice

Volumn 22, Issue 2, 2007, Pages 214-222

  Wiskin, Anthony E ^a   Wootton, Stephen A ^b   Beattie, Robert M ^a  

^a SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID;

BODY COMPOSITION; BODY MASS; BONE DENSITY; CALORIC INTAKE; CROHN DISEASE; DISEASE ASSOCIATION; ENERGY EXPENDITURE; ENTERIC FEEDING; HUMAN; INFLAMMATION; NUTRITIONAL REQUIREMENT; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; OSTEOPENIA; OSTEOPOROSIS; PEDIATRICS; REMISSION; REVIEW; CHILD; CHILD DEVELOPMENT; CHILD NUTRITION; GROWTH; INFANT; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD;

CHILD; CHILD DEVELOPMENT; CHILD NUTRITION PHYSIOLOGY; CHILD, PRESCHOOL; CROHN DISEASE; GROWTH; HUMANS; INFANT; NUTRITIONAL REQUIREMENTS; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT;

EID: 34249667118     PISSN: 08845336     EISSN: None     Source Type: Journal    
DOI: 10.1177/0115426507022002214     Document Type: Review

References (82)

1. Sawczenko A, Sandhu BK. Presenting features of inflammatory bowel disease in Great Britain and Ireland. Arch Dis Child. 2003;88:995-1000.
2. Markowitz J, Daum F. Growth impairment in pediatric inflammatory bowel disease. Am J Gastroenterol. 1994;89:319-326.
3. Thomas AG, Taylor F, Miller V. Dietary intake and nutritional treatment in childhood Crohn's disease. J Pediatr Gastroenterol Nutr. 1993;17:75-81.
4. Griffiths AM, Nguyen P, Smith C, Macmillan JH, Sherman PM. Growth and clinical course of children with Crohn's disease. Gut. 1993;34:939-943.
5. Hildebrand H, Karlberg J, Kristiansson B. Longitudinal growth in children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1994;18:165-173. (Pubitemid 24056474)
6. Lipson AB, Savage MO, Davies PS, Bassett K, Shand WS, Walker-Smith JA. Acceleration of linear growth following intestinal resection for Crohn disease. Eur J Pediatr. 1990;149:687-690.
7. Davies G, Evans CM, Shand WS, Walker-Smith JA. Surgery for Crohn's disease in childhood: influence of site of disease and operative procedure on outcome. Br J Surg. 1990;77:891-894.
8. Murch SH, Lamkin VA, Savage MO, Walker-Smith JA, MacDonald TT. Serum concentrations of tumour necrosis factor alpha in childhood chronic inflammatory bowel disease. Gut. 1991;32:913-917.
9. Thomas AG, Miller V, Taylor F, Maycock P, Scrimgeour GM, Rennie MJ. Whole body protein turnover in childhood Crohn's disease. Gut. 1992;33:675-677.
10. Thomas AG, Holly JM, Taylor F, Miller V. Insulin like growth factor-I, insulin like growth factor binding protein-1, and insulin in childhood Crohn's disease. Gut. 1993;34:944-947.
11. Beattie RM, Camacho-Hubner C, Wacharasindhu S, Cotterill AM, Walker-Smith JA, Savage MO. Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Crohn's disease. Clin Endocrinol. 1998;49:483-489.
12. Markowitz J, Grancher K, Rosa J, Aiges H, Daum F. Growth failure in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1993;16:373-380.
13. Kirschner BS, Klich JR, Kalman SS, deFavaro MV, Rosenberg IH. Reversal of growth retardation in Crohn's disease with therapy emphasising oral nutritional restitution. Gastroenterology. 1981;80:10-15.
14. Department of Health, Report on Health and Social Subjects No. 41: Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. London, England: HMSO; 1991.
15. Gavin J, Anderson CE, Bremner AR, Beattie RM. Energy intakes of children with Crohn's disease treated with enteral nutrition as primary therapy. J Hum Nutr Diet. 2005;18:337-342.
16. Mallett P, Murch S. Anorexia nervosa complicating inflammatory bowel disease. Arch Dis Child. 1990;65:298-300.
17. Ballinger A, El-Haj T, Perrett D, et al. The role of medial hypothalamic serotonin in the suppression of feeding in a rat model of colitis. Gastroenterology. 2000;118:544-553.
18. Jackson AA, Calder PC. Severe undernutrition and immunity. In: Gershwin ME, Nestle P, Keen CL, eds. Handbook of Nutrition & Immunity. Tototwa, NJ: Humana Press; 2004:71-92.
19. Singh Ranger G, Lamparelli MJ, Aldridge A, et al. Surgery results in significant improvement in growth in children with Crohn's disease refractory to medical therapy. Pediatr Surg Int. 2006;22:347-352.
20. Bannerjee K, Camacho-Hubner C, Babinska K, et al. Anti-inflammatory and growth stimulating effects precede nutritional restitution during enteral feeding in Crohn's disease. J Pediatr Gastroenterol Nutr. 2004;38:270-275.
21. Tenore A, Berman WF, Parks JS, Bongiovanni AM. Basal and stimulated serum growth hormone concentrations in inflammatory bowel disease. J Clin Endocrinol Metab. 1977;44:622-628.
22. Ballinger AB, Azooz O, El-Haj T, Poole S, Farthing MGF. Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis. Gut. 2000;46:694-700.
23. De Benedetti F, Alonzi T, Moretta A, et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I: a model for stunted growth in children with chronic inflammation. J Clin Invest. 1997;99:643-650.
24. Sawczenko A, Azooz O, Paraszczuk J, et al. Intestinal inflammation-induced growth retardation acts through IL-6 in rats and depends on the -174 IL-6 G/C polymorphism in children. Proc Natl Acad Sci U S A. 2005;102:13260-13265.
25. Wine E, Reif SS, Leshinsky-Silver E, et al. Pediatric Crohn's disease and growth retardation: the role of genotype, phenotype, and disease severity. Pediatrics. 2004;114:1281-1286.
26. Murphy J. Influence of diet and disease on human intestinal microflora, colonic function and faecal energy. [PhD thesis]. University of Southampton, Southampton, UK; 1991.
27. Vaisman N, Dotan I, Halack A, Niv E. Malabsorption is a major contributor to underweight in Crohn's disease patients in remission. Nutrition. 2006;22:855-859.
28. Filipsson S, Hulten L, Lindstedt G. Malabsorption of fat and vitamin B12 before and after intestinal resection for Crohn's disease. Scand J Gastroenterol. 1978;13:529-536.
29. Griffiths AM, Drobnies A, Soldin SJ, Hamilton JR. Enteric protein loss measured by faecal alpha-1-antitrypsin clearance in the assessment of Crohn's disease activity. J Pediatr Gastroenterol Nutr. 1986;5:907-910.
30. Gassull M, Cabre E. Nutrition in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care. 2001;4:561-569.
31. Chan AT, Fleming CR, O'Fallon WM, Huizenga KA. Estimated versus measured basal energy requirements in patients with Crohn's disease. Gastroenterology. 1986;91:75-78.
32. Stokes MA, Hill GL. Total energy expenditure in patients with Crohn's disease: measurement by the combined body scan technique. JPEN J Parenter Enteral Nutr. 1993;17:3-7.
33. Al-Jaouni R, Hebuterne X, Pouget I, Rampal P. Energy metabolism and substrate oxidation in patients with Crohn's disease. Nutrition. 2000;16:173-178.
34. Mingrone G, Capristo E, Greco AV, et al. Elevated diet-induced thermogenesis and lipid oxidation rate in Crohn's disease. Am J Clin Nutr. 1999;69:325-330.
35. Schneeweiss B, Lochs H, Zauner C, et al. Energy and substrate metabolism in patients with active Crohn's disease. J Nutr. 1999;129:844-848.
36. Jahnsen J, Falch JA, Mowinckel P, Aadland E. Body composition in patients with inflammatory bowel disease: a population-based study. Am J Gastroenterology. 2003;98:1556-1562.
37. Sentongo TA, Semeao EJ, Piccoli DA, Stallings VA, Zemel BS. Growth, body composition, and nutritional status in children and adolescents with Crohn's disease. J Pediatr Gastroenterol Nutr. 2000;31:33-40.
38. Azcue M, Rashid M, Griffiths A, Pencharz PB. Energy expenditure and body composition in children with Crohn's disease: effect of enteral nutrition and treatment with prednisolone. Gut. 1997;41:203-208.
39. Varille V, Cézard JP, de Lagausie P, et al. Resting energy expenditure before and after surgical resection of gut lesions in pediatric Crohn's disease. J Pediatr Gastroenterol Nutr. 1996;23:13-19.
40. Thomson MA, Bucolo S, Quirk P, Shepherd RW. Measured versus predicted resting energy expenditure in infants: a need for reappraisal. J Pediatr. 1995;126:22-27.
41. Hart JW, Bremner AR, Wootton SA, Beattie RM. Measured versus predicted energy expenditure in children with inactive Crohn's disease. Clin Nutr. 2005;24:1047-1055.
42. Cormier K, Mager D, Bannister L, et al. Resting energy expenditure in the parenterally fed pediatric population with Crohn's disease. JPEN J Parenter Enteral Nutr. 2005;29:102-107.
43. Boot AM, Bouquet J, Krenning EP, de Muinck Keizer-Schrama SM. Bone mineral density and nutritional status in children with chronic inflammatory bowel disease. Gut. 1998;42:188-194.
44. Burnham JM, Shults J, Semeao E, et al. Body composition alterations consistent with cachexia in children and young adults with Crohn disease. Am J Clin Nutr. 2005;82:413-420.
45. Trebble TM, Wootton SA, May A, et al. Essential fatty acid status in paediatric Crohn's disease: relationship to disease activity and nutritional status. Aliment Pharmacol Ther. 2003;18:433-442.
46. Socha P, Ryzko J, Koletzko B, et al. Essential fatty acid depletion in children with inflammatory bowel disease. Scand J Gastroenterol. 2005;40:573-577.
47. Trebble TM. Bone turnover and nutritional status in Crohn's disease: relationship to circulating mononuclear cell function and response to fish oil and antioxidants. Proc Nutr Soc. 2005;64:1-9.
48. Bousvaros A, Zurakowski D, Duggan C, et al. Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. J Pediatr Gastroenterol Nutr. 1998;26:129-135.
49. Filippi J, Al-Jaouni R, Wiroth JB, Hebuterne X, Schneider SM. Nutritional deficiencies in patients with Crohn's disease in remission. Inflamm Bowel Dis. 2006;12:185-191.
50. Silvennoinen JA, Karttunen TJ, Niemela SE, Manelius JJ, Lehtola J. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut. 1995;37:71-76.
51. Abitbol V, Roux C, Chaussade S, et al. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology. 1995;108:417-422.
52. Ahmed SF, Horrocks IA, Patterson T, et al. Bone mineral assessment by dual energy x-ray absorptiometry in children with inflammatory bowel disease: evaluation by age or bone area. J Pediatr Gastroenterol Nutr. 2004;38:276-280.
53. Cowan FJ, Warner JT, Dunstan FD, Evans WD, Gregory JW, Jenkins HR. Inflammatory bowel disease and predisposition to osteopenia. Arch Dis Child. 1997;76:325-329.
54. Habtezion A, Silverberg MS, Parkes R, Mikolainis S, Steinhart AH. Risk factors for low bone density in Crohn's disease. Inflamm Bowel Dis. 2002;8:887-892.
55. Klaus J, Armbrecht G, Steinkamp M, et al. High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease. Gut. 2002;51:654-658.
56. Axelsson CJ, Arnum S. Assessment of the therapeutic value of an elemental diet in chronic inflammatory bowel disease. Scand J Gastroenterol. 1977;12:89-95.
57. O'Morain C, Segal AW, Levi AJ. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. BMJ (Clin Res Ed). 1984;288:1859-1862.
58. O'Morain C, Segal AM, Levi AJ, Valman HB. Elemental diet in acute Crohn's disease. Arch Dis Child. 1983;58:44-47.
59. Papadopoulou A, Rawashdeh MO, Brown GA, McNeish AS, Booth IW. Remission following an elemental diet or prednisolone in Crohn's disease. Acta Paediatr. 1995;84:79-83.
60. Sanderson IR, Udeen S, Davies PS, Savage MO, Walker-Smith JA. Remission induced by an elemental diet in small bowel Crohn's disease. Arch Dis Child. 1987;62:123-127.
61. Newby EA, Sawczenko A, Thomas AG, Wilson D. Interventions for growth failure in childhood Crohn's disease. Cochrane Database Syst Rev. 2005;20:CD003873.
62. Beattie RM, Schiffrin EJ, Donnet-Hughes A, et al. Polymeric nutrition as the primary therapy in children with small bowel Crohn's disease. Aliment Pharmacol Ther. 1994;8:609-615.
63. Ruuska T, Savilahti E, Maki M, Ormala T, Visakorpi JK. Exclusive whole protein enteral diet versus prednisolone in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr. 1994;19:175-180.
64. Fell JM, Paintin M, Arnaud-Battandier F, et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther. 2000;14:281-289.
65. Afzal NA, Van Der Zaag-Loonen HJ, Arnaud-Battandier F, et al. Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition. Aliment Pharmacol Ther. 2004;20:167-172.
66. Griffiths AM, Ohlsson A, Sherman PM, Sutherland LR. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterology. 1995;108:1056-1067.
67. Fernandez-Banares F, Cabre E, Esteve-Comas M, Gassull MA. How effective is enteral nutrition in inducing clinical remission in active Crohn's disease? A meta-analysis of the randomized clinical trials. JPEN J Parenter Enteral Nutr. 1995;19:356-364.
68. Wight N, Scott BB, Wright N. Dietary treatment of active Crohn's disease. BMJ. 1997;314:454-455.
69. Zachos M, Tondeur M, Griffiths AM. Enteral nutrition therapy for inducing remission of Crohn's disease. Cochrane Database Syst Rev. 2001;3:CD000542.
70. Ludvigsson JF, Krantz M, Bodin L, Stenhammar L, Lindquist B. Elemental versus polymeric enteral nutrition in paediatric Crohn's disease. Acta Paediatr. 2004;93:327-335.
71. Heuschkel RB, Menache CC, Megerian JT, Baird AE. Enteral nutrition and corticosteroids in the treatment of acute Crohn's disease in children. J Pediatr Gastroenterol Nutr. 2000;31:8-15.
72. Modigliani R, Mary JY, Simon JF, et al. Clinical, biological, and endoscopic picture of attacks of Crohn's disease. Evolution on prednisolone. Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives. Gastroenterology. 1990;98:811-818.
73. Landi B, Anh TN, Cortot A, et al. Endoscopic monitoring of Crohn's disease treatment: a prospective, randomized clinical trial. The Groupe d'Etudes Therapeutiques des Affections Inflammatoires Digestives. Gastroenterology. 1992;102:1647-1653.
74. Bremner AR, Beattie RM. Therapy of Crohn's disease in childhood. Expert Opin Pharmacother. 2002;3:809-825.
75. Knight C, El-Matery W, Spray C, Sandhu BK. Long term outcome of nutritional therapy in paediatric Crohn's disease. Clin Nutr. 2005;24:775-779.
76. Johnson T, Macdonald S, Hill SM, Thomas A, Murphy MS. Treatment of active Crohn's disease in children using partial enteral nutrition with liquid formula: a randomised controlled study. Gut. 2006;55:356-361.
77. Wilschanski M, Sherman P, Pencharz P, Davis L, Corey M, Griffiths A. Supplementary enteral nutrition maintains remission in paediatric Crohn's disease. Gut. 1996;38:543-548.
78. Belli DC, Seidman E, Bouthillier L, et al. Chronic intermittent elemental diet improves growth failure in children with Crohn's disease. Gastroenterology. 1998;94:603-610.
79. Verma S, Holdsworth CD, Giaffer GH. Does adjuvant nutritional support diminish steroid dependency in Crohn's disease? Scand J Gastroenterol. 2001;36:383-388.
80. Shiloni E, Coronado E, Freund HR. Role of total parenteral nutrition in the treatment of Crohn's disease. Am J Surg. 1989;157:180-185.
81. Carter MJ, Lobo AJ, Travis SP, et al, for the British Society of Gastroenterology. Guidelines for the management of inflammatory bowel disease in adults. Gut. 2004;53(suppl V):v1-v16.
82. Escher JC, Taminau JA, Nieuwenhuis EE, Buller HA, Grand RJ. Treatment of inflammatory bowel disease: best available evidence. Inflamm Bowel Dis. 2003;9:34-58.